女性在下肢动脉粥样硬化斑块旋切术后再干预或大截肢风险并不高于男性
该研究分析了2014年1月至2019年9月间294例接受下肢动脉粥样硬化斑块旋切术的患者,其中女性125例(42.5%)。比较女性和男性无再干预生存率及无大截肢生存率,结果显示两性间4年无再干预生存率(68.8% vs 75.1%,P=0.88)和无大截肢生存率(97.6% vs 97.6%,P=0.41)均无显著差异。结论认为女性从下肢血运重建的斑块旋切术中获得的获益与男性相当。
要点
- 女性与男性4年无再干预生存率分别为68.8%和75.1%,无显著差异(P=0.88)。
- 女性与男性4年无大截肢生存率均为97.6%,无显著差异(P=0.41)。
- 按股腘或胫动脉区域、跛行或慢性肢体威胁性缺血、药物涂层球囊或普通球囊分层,两性无再干预生存率均无显著差异。
核心结论
- 与男性相比,女性接受下肢动脉粥样硬化斑块旋切术获得的获益相当,两性间长期再干预或大截肢无差异。
研究设计与样本
- 分析2014年1月至2019年9月间294例接受下肢动脉粥样硬化斑块旋切术的患者,其中女性125例(42.5%)。
- 采用Kaplan-Meier生存分析比较两性无再干预生存率和无大截肢生存率,多因素logistic回归分析根据性别确定再干预和大截肢的校正比值比。
- 按解剖区域(股腘 vs 胫动脉)、指征(跛行 vs 慢性肢体威胁性缺血)和球囊类型(药物涂层球囊 vs 普通球囊血管成形术)进行亚组分析。
主要发现
- 女性与男性相比,更可能为黑人(28.0% vs 16.6%;P=0.018)、不吸烟(44.8% vs 21.3%;P<0.001)和表现为慢性肢体威胁性缺血(55.2% vs 43.2%;P=0.042)。
- 两性在斑块旋切区域、病变类型或球囊类型方面无差异。
- Kaplan-Meier分析显示两性4年无再干预生存率(68.8% vs 75.1%;P=0.88)和无大截肢生存率(97.6% vs 97.6%;P=0.41)相似。
- 按股腘区域(67.9% vs 70.8%;P=0.69)或胫动脉区域(76.2% vs 83.9%;P=0.68)分组,两性无再干预生存率相似。
- 指征(跛行 vs 慢性肢体威胁性缺血)对女性(64.5% vs 69.6%;P=0.28)或男性(68.5% vs 76.7%;P=0.84)的无再干预生存率均无影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our objective was to compare short-term and long-term differences in reintervention-free and major amputation-free survival between female and male patients undergoing lower extremity atherectomy for peripheral artery disease. METHODS: We analyzed lower extremity atherectomy procedures performed on 294 patients between January 2014 and September 2019. Reintervention was defined as either open bypass or endovascular procedure to the same region following the index operation. Kaplan-Meier (KM) survival analysis was performed to compare reintervention-free and major amputation-free survival between sexes. Multivariate logistic regression analyses were performed to determine the adjusted odds of reintervention and major amputation based on sex. We conducted subgroup analyses by anatomic region (femoropopliteal vs. tibial), indication (claudication vs. chronic limb-threatening ischemia (CLTI)), and balloon type (drug-coated balloon (DCB) versus plain balloon angioplasty (POBA)) across sexes. RESULTS: Of the 294 patients, 125 (42.5%) were female. Compared to men, women receiving atherectomy were more likely to be Black (28.0% vs. 16.6%; P = 0.018), a nonsmoker (44.8% vs. 21.3%; P < 0.001), and present with CLTI (55.2% vs. 43.2%; P = 0.042). There were no differences in atherectomy region, lesion type, or balloon type between sexes. KM analysis showed similar 4-year reintervention-free survival (68.8% vs. 75.1%; P = 0.88) and major amputation-free survival (97.6% vs. 97.6%; P = 0.41) between sexes. Women and men had similar reintervention-free survival when grouped by femoropopliteal (67.9% vs. 70.8%; P = 0.69) or tibial (76.2% vs. 83.9%; P = 0.68) atherectomy region. Indication (claudication versus CLTI) did not affect reintervention-free survival in either women (64.5% vs. 69.6%; P = 0.28) or men (68.5% vs. 76.7%; P = 0.84). KM curves for DCB versus POBA were also similar between sexes and showed an early benefit in reintervention rate favoring DCB, which dissipated in both women (65.4% vs. 72.7%; P = 0.61) and men (75.5% vs. 78.4%; P = 0.18) by 3 years. CONCLUSIONS: Compared to men, women demonstrate commensurate benefit from atherectomy for lower extremity revascularization. There were no differences seen in long-term reintervention or major amputation between sexes.
引用
- Israni N, Lee J, Bai H, et al. Women are Not at Higher Risk for Reintervention or Major Amputation after Lower Extremity Atherectomy for Peripheral Artery Disease. Ann Vasc Surg. 2023. PMID: 37080286. doi:10.1016/j.avsg.2023.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。